Reaction

Maculopathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,525 reports · 69 co-occurring drugs

As of the last recalculation, Maculopathy appears in 3,525 FAERS reports alongside 69 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 29.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ranibizumab	126	29.0	29.2
Hydroxychloroquine	203	17.0	17.0
Cefuroxime	23	12.0	12.0
Amlodipine Besylate And Valsartan	20	10.7	10.7
Nitrofurantoin	27	9.7	9.7
Hyoscyamine Sulfate	15	9.7	9.7
Nitrofurantoin (Monohydrate/Macrocrystals)	27	9.6	9.6
Hydroxyzine	76	9.6	9.6
Estradiol Gel 0.1%	67	8.9	8.9
Estradiol Transdermal	67	8.9	8.9
Topiramate	128	8.4	8.4
Dicyclomine Hydrochloride	20	8.3	8.3
Aflibercept	39	7.5	7.5
Oxybutynin	36	7.3	7.3
Tretinoin	9	6.6	6.6
Oxycodone And Acetaminophen Tablets	13	6.5	6.5
Tizanidine	25	6.2	6.2
Estradiol	89	6.2	6.2
Sildenafil Powder,	36	6.0	6.0
Timolol Maleate	10	6.0	6.0
Tolterodine Tartrate	9	5.9	5.9
Prednisolone Acetate	10	5.7	5.7
Abacavir Sulfate	9	5.5	5.5
Brinzolamide	8	5.4	5.5
Sumatriptan Succinate	22	5.2	5.2
Faricimab	7	5.1	5.1
Niacin	10	5.1	5.1
Triamcinolone Acetonide Ointment Usp, 0.05%	20	5.1	5.1
Carboxymethylcellulose Sodium	8	5.0	5.0
Sucralfate Oral	12	5.0	5.0
Sucralfate Oral Suspension	12	5.0	5.0
Ritonavir 100 Mg	12	4.8	4.8
Sildenafil	46	4.7	4.7
Sumatriptan	30	4.7	4.7
Moxifloxacin Hydrochloride	16	4.7	4.7
Cyclobenzaprine	39	4.7	4.7
Azelastine	14	4.6	4.6
Latanoprost	37	4.4	4.4
Sertraline	83	4.3	4.3
Travoprost	6	4.1	4.1
Hydroxychloroquine Sulfate	62	4.1	4.1
Rifampin	10	4.1	4.1
Triamcinolone Acetonide	21	4.0	4.0
Lamivudine Oral	17	4.0	4.0
Fingolimod Hcl	57	3.9	3.9
Lopinavir And Ritonavir	9	3.9	3.9
Thyroid, Porcine	7	3.9	3.9
Lamivudine	20	3.8	3.8
Mirabegron	25	3.8	3.8
Conjugated Estrogens	36	3.7	3.7
Ritonavir	18	3.7	3.7
Estrogens, Conjugated	36	3.6	3.6
Mesalamine	34	3.6	3.6
Bupropion	27	3.6	3.6
Deferasirox	16	3.6	3.6
Oxycodone And Acetaminophen	14	3.6	3.6
Amikacin	10	3.5	3.5
Timolol	7	3.4	3.4
Brimonidine Tartrate	10	3.3	3.3
Siponimod	5	3.3	3.3
Dexlansoprazole	21	3.0	3.0
Sildenafil Citrate	63	3.0	3.0
Vemurafenib	5	2.5	2.5
Linaclotide	11	2.4	2.4
Vigabatrin	6	2.4	2.4
Lifitegrast	6	2.2	2.2
Bimatoprost	9	1.8	1.8
Fam-Trastuzumab Deruxtecan-Nxki	3	1.8	1.8
Galcanezumab-Gnlm	5	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.